Conference recordings now available

Don't miss out on insights from leading experts.

Lista: Årets mest framstående medicinska uppfinningar

Den subkutana formen av det svenskutvecklade alzheimerläkemedlet Leqembi lyfts fram när Time presenterar sin årliga lista över de bästa uppfinningarna 2025.

Several departures at the top at Nykode

Members of both the management and the board are leaving the Norwegian biotech company Nykode.

Quality solutions for medical device R&D applications

From R&D to the quality assurance of series production in medical device manufacturing.

”Underbehandling av kronisk njursjukdom – stuprörstänkandet kostar liv och resurser”

Trots tydliga riktlinjer är patienter med kronisk njursjukdom kraftigt underbehandlade i Sverige idag. Många har dessutom omfattande samsjuklighet och skulle be...

Pharma Search and Advice AB

Starka resultat för genterapi – pausas ändå

En ny genterapi förbättrade synen hos elva av tolv patienter med en extremt sällsynt ärftlig ögonsjukdom. Men trots de starka resultaten i en klinisk studie har...

Improve Productivity and Accessibility with Award-winning Human-Centered Design

Enhance your workflow with integrated intelligence.

”Klurigare än bakterier” – därför blir svåra svampinfektioner vanligare

Det är inte för inte som jorden kallas svamparnas planet. En livsform som är miljardtals år, närmare släkt med djur än med växter och spelar en avgörande roll f...

Maximal prestanda i varje massaprocess – möt Waukesha U2 ND

I den krävande världen av pappers- och massaproduktion krävs utrustning som levererar hållbarhet, effektivitet och driftsäkerhet.

Norwegian company wins bidding battle for Sensidose

The lengthy battle to acquire medical device company Sensidose is apparently over. Generic medicines company EQL Pharma is pulling out, selling its shares and l...

Antikroppar från lama hjälpte mot 17 olika ormars bett

Ett motgift baserat på antikroppar från en lama och en alpacka lyckades neutralisera gift från några av världens mest giftiga ormar i en preklinisk studie.

Final assembly inspection of medical plastics

Technical paper by ZEISS Medical Industry Solutions.

LINK Medical recruits Swedish CEO

The Norwegian Contract Research Organization LINK Medical has recruited Anders Göransson as the new CEO.

FDA approves first non-opioid pain reliever in over 20 years

For the first time in decades, a new type of acute pain medication that is not an opioid has been approved in the USA.

We desire talent to come here, but are we genuinely welcoming them?

Sweden faces significant challenges in creating a truly inclusive environment that makes international professionals feel welcome, valued, and able to build mea...

Norway rejects national life science strategy – sees no need

The Norwegian Arbeiderpartiet rejects a proposal that Norway should develop its own life science strategy.

Cantargia utser Hilde Steineger till ny vd

Det Lundbaserade forskningsbolaget Cantargia har utsett Hilde Steineger till ny vd.

Marie Gårdmark: “What to expect from Trump’s second term?”

One may complain about the complex multinational system in EU, but it gives us some predictability that cannot be easily overturned by different member states p...

New drug to simplify treatment of hemophilia

A new type of treatment for hemophilia, which only needs to be administered every two months, has been approved by the U.S. Food and Drug Administration (FDA).

How the Foreign Office will promote Swedish life science exports

The broadness and innovative strength keep Swedish life science exports strong, but the protectionist tendencies in the world are worrying, says Camilla Melland...

First preterm infants study – a vital step for Neola

After years of developing an advanced lung monitoring system, Neola Medical has received some delightful news: permission to start its first clinical study on p...

The future of healthcare in focus: ”Together, things happen”

In march, it’s once again time for Fokus Patient, an event for the industry where the patients’ perspective takes center stage. It’s a great way to spread knowl...

She is CSL Behring's new Nordic General Manager

Since the beginning of january, Helena Bragd is the new Nordic General Manager for the biotech company CSL Behring and CEO of CSL Behring AB.